About: SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. It also develops a non-IOL-based, ring-shaped, sustained-release implant with bimatoprost. SpyGlass Pharma, Inc. was formerly known as SpyGlass Ophthalmics, Inc. and changed its name to SpyGlass Pharma, Inc. in April 2021. The company was headquartered in 2019 and is based in Irvine, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $27.50 (-4.91%)
SGPNASDAQSpyGlass Pharma, Inc.
SpyGlass Pharma, Inc. share price
SGP price activity
Last Price
$27.500
Change (24hr)
-1.42 USD (-4.91%)
Volume
78.44K
Volume (4w avg)
-
Open
$28.77
Day Range
$27.09 - $28.77
Previous Close
$28.92
Last Trade
09 Sep, 8:00 pm GMT+0
Delayed
09 Sep, 8:00 pm GMT+0
SGP price performance
Delayed
09 Sep, 8:00 pm GMT+0
SGP Market Signals